Professor Dr. Detlev Ganten is a specialist in pharmacology and molecular medicine and is one of the leading scientists worldwide in the field of hypertension.
Professor Ganten is the founding president of the World Health Summit. He is Chairman of the Foundation Board of the Charité Foundation and editor of the Journal of Molecular Medicine. Other roles held include Chairman of the Board of Trustees of the Max Planck Institutes of Colloids and Interfaces and Molecular Plant Physiology (Potsdam-Golm) and Chairman of the Board of Trustees of the Ethnological Museum Dahlem of the Prussian Cultural Heritage Foundation.
From 2004 to 2008 Professor Ganten was CEO of the Charité – Universitätsmedizin Berlin and from 1991 to 2004 Founding Director and CEO of the Max Delbrück Center for Molecular Medicine.
Professor Ganten has been the recipient of many international awards and prizes including the Chavez Award of the International Society of Hypertension, the Sechenev Medal of the Medical Academy Moscow, the Franz Gross Science Award of the German League for Combating High Blood Pressure, the Heilmeyer Medal of the Society for Progress in Internal Medicine, the Max Planck Research Award, the Okamoto Award, the CIBA Award of the Council for High Blood Pressure Research of the American Heart Association, and the Humboldt Medal of the Society of German Natural Scientists and Physicians.
Professor Ganten received the Order of Merit of the State of Berlin, the Federal Cross of Merit of Germany, and the insignia of Officer of the Legion of Honor of the French Republic.